Objective Hypoparathyroidism is usually controlled with calcium and vitamin-D supplements;
in very few cases this treatment fails and teriparatide may be an alternative. We report the …

Background. Teriparatide is a recombinant human parathormone (PTH 1–34) currently
approved for the treatment of osteoporosis with high risk of fracture. In this study, we analyze …

Objective: We describe calcium homeostasis during pregestation and gestation in a woman
with iatrogenic hypoparathyroidism, treated with continuous subcutaneous recombinant …

Introduction: Hypocalcaemia is a common postoperative complication, both after the
resection of parathyroid adenoma associated with primary hyperparathyroidism and after …

Though hypoparathyroidism is not an uncommon diagnosis, it is an unusual cause of
seizures in adults. The authors report a case of late onset epilepsy due to idiopathic …

Introduction Hypoparathyroidism is considered a rare endocrine disease. Despite being a
deficiency of parathyroid hormone, the standard therapy is based on oral calcium and active …

El tratamiento convencional del hipoparatiroidismo resulta insuficiente en algunos casos
graves. La terapéutica con PTH1-34 es una opción para considerar. Objetivos: describir la …

Se presenta un paciente con enfermedad renal crónica e hipoparatiroidismo posquirúrgico
tratado con calcitriol y carbonatocálcico, a quien se le practicó trasplante renal. Meses más …

The conventional treatment of hypoparathyroidism consists of vitamin D analogues in
combination with oral calcium supplementation. This treatment modalities induce chronic …

2. Treatment of idiopathic short stature, also called non-growth hormone deficient short
stature, defined by height standard deviation score (SDS)≤-2.25 (1.2 percentile), and …